pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
AAT-076
Pain
AskAt Inc
0
catalysts
Preclinical
AAV-ATP7A Gene Therapy
Menkes Disease (Kinky Hair Disease)
Cyprium Therapeutics Inc
0
catalysts
Preclinical
AAV-RDH12
$MGTX
MeiraGTx Holdings plc
0
catalysts
Preclinical
AAV9 Gene Replacement Therapy
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
← prev
page 47 of 231
next →
131
Pain
89
Neurology
1
Neurogt Inc
0
catalysts
Phase 2
AAVB-039
Juvenile Macular Degeneration (Stargardt Disease)
AAVantgarde Bio Srl
0
catalysts
Preclinical
AAVCOVID
Coronavirus Disease 2019 (COVID-19)
Massachusetts General Hospital
0
catalysts
Phase 2
AB-001
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Artbio Inc
0
catalysts
Phase 2
AB-002
Thrombosis
Lysyl oxidase homolog 2
Aronora Inc
0
catalysts
Phase 2
AB-1003
Limb-Girdle Muscular Dystrophy
Asklepios BioPharmaceutical Inc
0
catalysts
Phase 2
AB-1009
Pompe Disease
Asklepios BioPharmaceutical Inc
0
catalysts
Phase 1
AB-1015
Epithelial Ovarian Cancer
Arsenal Biosciences Inc
0
catalysts
Preclinical
AB-2010
Idiopathic Pulmonary Fibrosis
Alveolus Bio Inc
0
catalysts
Phase 1
AB-207
Muscle Atrophy
Angiocrine Bioscience Inc
0
catalysts
Phase 2
AB-2100
Metastatic Renal Cell Carcinoma
Arsenal Biosciences Inc
0
catalysts
Phase 1
AB-598
Adenocarcinoma Of The Gastroesophageal Junction
$RCUS
Arcus Biosciences, Inc.
0
catalysts
Phase 1
ABA-101
Primary Progressive Multiple Sclerosis (PPMS)
Abata Therapeutics
0
catalysts
ABACAVIR
ABACAVIR (ABACAVIR)
HETERO LABS LTD III
0
catalysts
ABACAVIR AND LAMIVUDINE
ABACAVIR AND LAMIVUDINE (ABACAVIR AND LAMIVUDINE)
LAURUS
0
catalysts
Phase 1
ABBV-547
Psoriasis
$ABBV
AbbVie Inc.
0
catalysts
Phase 2
ABBVCLS-628
Polycystic Kidney Disease
Calico Life Sciences LLC
0
catalysts
Phase 1
ABD-147
Neuroendocrine Carcinoma
Abdera Therapeutics Inc
0
catalysts
Preclinical
ABG-023
Hyperinsulinemia
AmideBio LLC
0
catalysts
Phase 2
ABI-110
Polypoidal Choroidal Vasculopathy
Avirmax Inc
0
catalysts
Phase 1
ABI-1179
Genital Herpes
$GILD
GILEAD SCIENCES, INC.
0
catalysts
Preclinical
ABI-171
Idiopathic Pulmonary Fibrosis
Avanti Biosciences Inc
0
catalysts
ABIGALE LO
ABIGALE LO (ESTRADIOL AND NORETHINDRONE ACETATE)
XIROMED
0
catalysts
Preclinical
ABN-501
Solid Tumor
Abion Inc
0
catalysts
Phase 2
ABO-101
Primary Hyperoxaluria Type I
Chiesi Farmaceutici SpA
0
catalysts
Preclinical
ABO-503
Retinal Degeneration
$ABEO
ABEONA THERAPEUTICS INC.
0
catalysts
Preclinical
ABO-504
Juvenile Macular Degeneration (Stargardt Disease)
$ABEO
ABEONA THERAPEUTICS INC.
0
catalysts
